These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 119319)

  • 1. [In vitro study on the problem of optimal gentamicin therapy in leukopenic patients: short injections or parenteral infusions?].
    Gerber A; Wiprächtiger P; Spichiger U; Lebek G
    Schweiz Med Wochenschr; 1979 Dec; 109(47):1902-3. PubMed ID: 119319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constant infusions vs. intermittent doses of gentamicin against Pseudomonas aeruginosa in vitro.
    Gerber AU; Wiprächtiger P; Stettler-Spichiger U; Lebek G
    J Infect Dis; 1982 Apr; 145(4):554-60. PubMed ID: 6802906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoglycoside-selected subpopulations of Pseudomonas aeruginosa: characterization and virulence in normal and leukopenic mice.
    Gerber AU; Craig WA
    J Lab Clin Med; 1982 Nov; 100(5):671-81. PubMed ID: 6813409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal activity of cefoperazone in comparison with other beta-lactam antibiotics and gentamicin.
    Welch DF; Matsen JM
    Clin Ther; 1980; 3(Spec Issue):127-9. PubMed ID: 6446385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bolus injection, short infusion or intravenous drip of aminoglycoside antibiotics? In vivo study with netilmicin and Pseudomonas aeruginosa].
    Brugger HP; Gerber AU; Feller-Segessenmann C
    Schweiz Med Wochenschr; 1983 Dec; 113(49):1858-60. PubMed ID: 6427922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial activity of liposomal gentamicin against Pseudomonas aeruginosa: a time-kill study.
    Rukholm G; Mugabe C; Azghani AO; Omri A
    Int J Antimicrob Agents; 2006 Mar; 27(3):247-52. PubMed ID: 16472992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bacteriostatic activity of azlocillin, gentamycin, amikacin singly or in combination on 200 strains of Pseudomonas aeruginosa].
    Texier-Maugein J; Fourche J; Mormede M; Mazaud C; Bébéar C
    Pathol Biol (Paris); 1986 May; 34(5):415-8. PubMed ID: 3095774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipseudomonal activity of simulated infusions of gentamicin alone or with piperacillin assessed by serum bactericidal rate and area under the killing curve.
    Tisdale JE; Pasko MT; Mylotte JM
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1500-5. PubMed ID: 2510592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosing problems of gentamicin in critically ill patients.
    Regazzi BM; Rondanelli R; Dionigi RV; Mapelli A; Gasati A
    Int J Clin Pharmacol Res; 1986; 6(5):355-9. PubMed ID: 3781698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental investigation on various administration methods of gentamicin. Comparison of the effect of gentamicin on phagocytosis].
    Iwasaki Y; Yamashita N; Jozaki K; Tojo M; Sato Y; Iwata S; Akita H; Sunakawa K; Oikawa T; Osano M
    Jpn J Antibiot; 1983 Mar; 36(3):547-51. PubMed ID: 6410099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacodynamics of the new fluoroquinolone ABT492 and ciprofloxacin with Escherichia coli and Pseudomonas aeruginosa in an in vitro dynamic model.
    Zinner SH; Vostrov SN; Alferova IV; Lubenko IY; Portnoy YA; Firsov AA
    Int J Antimicrob Agents; 2004 Aug; 24(2):173-7. PubMed ID: 15288317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transtympanic versus sustained-release administration of gentamicin: kinetics, morphology, and function.
    Hoffer ME; Allen K; Kopke RD; Weisskopf P; Gottshall K; Wester D
    Laryngoscope; 2001 Aug; 111(8):1343-57. PubMed ID: 11568567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a pharmacodynamic need for the use of continuous versus intermittent infusion with ceftazidime against Pseudomonas aeruginosa? An in vitro pharmacodynamic model.
    Alou L; Aguilar L; Sevillano D; Giménez MJ; Echeverría O; Gómez-Lus ML; Prieto J
    J Antimicrob Chemother; 2005 Feb; 55(2):209-13. PubMed ID: 15650000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of combined gentamicin-corticosteroid treatment on gentamicin-resistant Pseudomonas keratitis.
    Stern GA; Okumoto M; Friedlaender M; Smolin G
    Ann Ophthalmol; 1980 Sep; 12(9):1011-4. PubMed ID: 6821445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Susceptibility of Pseudomonas aeruginosa to aztreonam in comparison to other pseudomonas-active beta-lactam antibiotics and gentamicin].
    Wundt W; Lange KP; Baumgärtner M
    Arzneimittelforschung; 1985; 35(8):1322-5. PubMed ID: 3935123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-encapsulation of gallium with gentamicin in liposomes enhances antimicrobial activity of gentamicin against Pseudomonas aeruginosa.
    Halwani M; Yebio B; Suntres ZE; Alipour M; Azghani AO; Omri A
    J Antimicrob Chemother; 2008 Dec; 62(6):1291-7. PubMed ID: 18931388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed resistance selection for doripenem when passaging Pseudomonas aeruginosa isolates with doripenem plus an aminoglycoside.
    Huynh HK; Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 2006 Jul; 55(3):241-3. PubMed ID: 16725297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of Streptococcus viridans in gentamicin-supplemented McCarey-Kaufman medium.
    Baer JC; Nirankari VS; Glaros DS
    Cornea; 1989; 8(2):131-4. PubMed ID: 2496953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of methods for assessing in vitro antibiotic synergism against Pseudomonas and Serratia.
    Weinstein RJ; Young LS; Hewitt WL
    J Lab Clin Med; 1975 Nov; 86(5):853-62. PubMed ID: 810533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keratotomy model of pseudomonas keratitis: gentamicin chemotherapy.
    Brockman EB; Tarantino PA; Hobden JA; Hill JM; O'Callaghan RJ; Kaufman HE; Insler MS
    Refract Corneal Surg; 1992; 8(1):39-43. PubMed ID: 1554638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.